Clinical Trials Directory

Trials / Completed

CompletedNCT01598376

A Prospective Double-blind Interventional Study of Tissue Reaction to Polyglycolic Acid Sutures in Human Skin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
The Royal Bournemouth Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Objective To investigate the tissue reaction produced by implanted polyglactin suture material in normal human skin and to determine the effect of suture gauge on this response. Design A prospective, double blind, randomized clinical trial using a novel ethical study design. Both the patient and clinician analyzing the histology were blinded to the suture gauge used. Participants A total of 42 consecutive patients presenting to an oculoplastic clinic with involutional entropion and horizontal eyelid laxity, who provided written consent to participate, were enrolled in the study. Intervention Patients were randomly allocated to 5/0 or 7/0 Vicryl™ test suture groups. Patient symptoms were alleviated during the wait for definitive surgery by the placement of temporary eyelid everting sutures including a test suture. After 28 days, entropion correction was achieved by a Quickert procedure which includes excision of an eyelid wedge. Histological analysis was carried out, blind to the suture gauge used, on the excised eyelid containing the test suture. Main outcome measure Defined histological parameters of suture-related granulomas were measured at multiple levels. Data included granuloma outer diameter, central cellular diameter, giant cell number and area of fibrous coat (calculated from the coat diameter and thickness at multiple levels) and a statistical comparison made between the 5/0 and 7/0 suture gauge groups.

Conditions

Interventions

TypeNameDescription
PROCEDURE7/0 vicryl suture7/0 vicryl test suture placed as one of 3 everting sutures
PROCEDURE5/0 vicryl test suture5/0 vicryl test suture placed as one of 3 everting sutures

Timeline

Start date
2010-06-01
Primary completion
2011-01-01
Completion
2011-03-01
First posted
2012-05-15
Last updated
2012-05-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01598376. Inclusion in this directory is not an endorsement.